4-Benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists
US6284774A · kind A · utility
33Cited by
3References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2000 |
| Grant date | Sep 4, 2001 |
| Priority date | — |
| Expiry date | Oct 31, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel 4-Benzyl piperidine alkylsulfoxide heterocycles are disclosed and their use as subtype selective NMDA receptor antagonists, particularly for the treatment of Parkinson's disease, most preferably in combination with L-DOPA.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.